Article
Exploring the <i>in-situ</i> evolution of Nitrofurantoin resistance in clinically derived Uropathogenic <i>Escherichia coli</i> isolates
2022-07-20
Abstract excerpt
<h4>BACKGROUND</h4> Nitrofurantoin has been re-introduced as a first-choice antibiotic to treat uncomplicated acute urinary tract infections in England and Wales. Its mode of action involves initial reduction by nitroreductases, to generate electrophilic intermediates that inhibit protein and nucleic acid synthesis. Highly effective against common uropathogens such as Escherichia coli , its use is accompanied by...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3554ea17-cd2a-58e1-9e93-051a09a9c476
- DOI
- 10.1101/2022.07.19.500598
